Wells Fargo
FLNA

Wells Fargo’s Filana Therapeutics FLNA Stock Holding History

Wells Fargo’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,000
Closed -$418K – 7691
2022
Q3 		$418K Buy
+10,000
New +$270K ﹤0.01% 3810

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Wells Fargo's FLNA Position: Q2 2026 in Review

Wells Fargo increased its Filana Therapeutics (FLNA) stake by 24% in Q2 2026, buying an estimated $2.91K and bringing the position to 10,466 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6026.

Wells Fargo first reported a position in FLNA in Q1 2014 and has held it in 50 quarters since. The position peaked at $1.76M in Q4 2021. 84 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Wells Fargo held 10,466 shares of Filana Therapeutics worth $12.5K as of Q2 2026.
  • Wells Fargo bought 2,045 Filana Therapeutics shares in Q2 2026, an estimated $2.91K.
  • Filana Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6026 holding.
  • Wells Fargo first reported a position in Filana Therapeutics in Q1 2014 and has held it in 50 quarters since.
  • Wells Fargo's Filana Therapeutics position peaked at $1.76M in Q4 2021.
  • 84 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.